| Synonyms: | |
| Status: | Phase 2 |
| Entry Type: | Small molecule |
| Molecule Category: | Salt |
| UNII: | GBW044919E |
| Parent Compound: | FOSBRETABULIN |
| InChI Key | FIDMEHCRMLKKPZ-YSMBQZINSA-N |
|---|---|
| Smile | |
| InChI |
|
| Property Name | Value |
|---|---|
| Molecular Formula | C22H32NO11P |
| Molecular Weight | 517.47 |
| AlogP | 3.36 |
| Hydrogen Bond Acceptor | 6.0 |
| Hydrogen Bond Donor | 2.0 |
| Number of Rotational Bond | 8.0 |
| Polar Surface Area | 103.68 |
| Molecular species | ACID |
| Aromatic Rings | 2.0 |
| Heavy Atoms | 27.0 |
| Action | Mechanism of Action | Reference |
|---|---|---|
| DISRUPTING AGENT | Tubulin disrupting agent | PubMed |
| Mesh Heading | Maximum Phase | Mesh ID | Reference |
|---|---|---|---|
| Neuroendocrine Tumors | 2 | D018358 | ClinicalTrials |
| Ovarian Neoplasms | 2 | D010051 | ClinicalTrials |
| Resources | Reference |
|---|---|
| ChEMBL | CHEMBL2105643 |
| FDA SRS | GBW044919E |
| PubChem | 10186184 |